Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Paz

Showing results (41-50 of 258) with videos related to

Pageof 26
Sort By:
Critical Care Medicine|April 7, 2007
Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003Viktor Y Dombrovskiy, Andrew A Martin, Jagadeeshan Sunderram, et al.
Revista Argentina De Microbiologia|October 14, 2006
[Helicobacter pylori and active chronic gastritis]L Castello, I Martinelli, L Paz, et al.
Critical Care Medicine|January 15, 1998
Effect of clinical outcomes data on intensive care unit utilization by bone marrow transplant patientsH L Paz, A Garland, M Weinar, et al.
Journal of Bacteriology|November 7, 2006
Naturally occurring adenines within mRNA coding sequences affect ribosome binding and expression in Escherichia coliJay E Brock, Robert L Paz, Patrick Cottle, et al.
Critical Care Medicine|January 27, 2007
Occurrence and outcomes of sepsis: influence of raceViktor Y Dombrovskiy, Andrew A Martin, Jagadeeshan Sunderram, et al.
Critical Care Medicine|November 9, 2005
Facing the challenge: decreasing case fatality rates in severe sepsis despite increasing hospitalizationsViktor Y Dombrovskiy, Andrew A Martin, Jagadeeshan Sunderram, et al.
Chest|November 1, 1994
The automated implantable cardiac defibrillator. Prophylaxis in cardiac sarcoidosisH L Paz, D J McCormick, S P Kutalek, et al.
BMJ Case Reports|July 31, 2013
Massive splenomegalyHugo L Paz-Y-Mar, Alexei Gonzalez-Estrada, M Chadi Alraies
Medicina|August 26, 1998
[Paraneoplastic neuropathy with positive anti-Hu]I Casas Parera, D Fischman, L Paz, et al.
Journal of Clinical Pharmacy and Therapeutics|September 14, 2010
A cost-effectiveness analysis of sunitinib in patients with metastatic renal cell carcinoma intolerant to or experiencing disease progression on immunotherapy: perspective of the Spanish National Health SystemL Paz-Ares, J G del Muro, E Grande, et al.
Pageof 26

Showing results (41-50 of 258) with videos related to

Sort By:
Pageof 26
Critical Care Medicine|April 7, 2007
Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003Viktor Y Dombrovskiy, Andrew A Martin, Jagadeeshan Sunderram, et al.
Revista Argentina De Microbiologia|October 14, 2006
[Helicobacter pylori and active chronic gastritis]L Castello, I Martinelli, L Paz, et al.
Critical Care Medicine|January 15, 1998
Effect of clinical outcomes data on intensive care unit utilization by bone marrow transplant patientsH L Paz, A Garland, M Weinar, et al.
Journal of Bacteriology|November 7, 2006
Naturally occurring adenines within mRNA coding sequences affect ribosome binding and expression in Escherichia coliJay E Brock, Robert L Paz, Patrick Cottle, et al.
Critical Care Medicine|January 27, 2007
Occurrence and outcomes of sepsis: influence of raceViktor Y Dombrovskiy, Andrew A Martin, Jagadeeshan Sunderram, et al.
Critical Care Medicine|November 9, 2005
Facing the challenge: decreasing case fatality rates in severe sepsis despite increasing hospitalizationsViktor Y Dombrovskiy, Andrew A Martin, Jagadeeshan Sunderram, et al.
Chest|November 1, 1994
The automated implantable cardiac defibrillator. Prophylaxis in cardiac sarcoidosisH L Paz, D J McCormick, S P Kutalek, et al.
BMJ Case Reports|July 31, 2013
Massive splenomegalyHugo L Paz-Y-Mar, Alexei Gonzalez-Estrada, M Chadi Alraies
Medicina|August 26, 1998
[Paraneoplastic neuropathy with positive anti-Hu]I Casas Parera, D Fischman, L Paz, et al.
Journal of Clinical Pharmacy and Therapeutics|September 14, 2010
A cost-effectiveness analysis of sunitinib in patients with metastatic renal cell carcinoma intolerant to or experiencing disease progression on immunotherapy: perspective of the Spanish National Health SystemL Paz-Ares, J G del Muro, E Grande, et al.
Pageof 26